CNN: Moderna applies for FDA authorization of its COVID-19 vaccine
First patient enrolled in UC/UC Health Moderna vaccine trial tells his story
Jarelle Marshall, the first patient administered a dose in the UC/UC Health Moderna COVID-19 vaccine trial was interviewed by CNN about his experience. Marshall received the first dose on August 25, 2020 with a follow up dose about four weeks later.
Jarelle Marshall receives the first dose of the UC/UC Health Moderna COVID-19 vaccine trial. Photo/Colleen Kelley/UC Creative + Brand
When asked by CNN host Don Lemon about what getting a dose was like, Marshall said, "Other than a sore arm I didn't have any really negative side effects. After the second injection, the day after, my temperature rose a couple degrees around 99 for about a day which made me a little nervous. I was checking my temperature every hour or two. But after that, you know, I was fine. I didn't get sick or didn't have any problems."
Marshall also said that one of the reasons he volunteered for the trial was to set an example for his son.
"I always tell my son, what really matters is what you do when people aren't looking."
Watch the entire segment here and read more about the UC/UC Health Moderna vaccine trial here.
Lead photo Colleen Kelley/UC Creative + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Struggling with daily HIV meds?
March 23, 2026
For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.
Extended-release buprenorphine viable, safe during pregnancy
March 23, 2026
MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.
Why are we so unhappy?
March 23, 2026
Suzie White, assistant professor in the School of Education, at the University of Cincinnati, spoke with Newsweek about the results of the 2026 World Happiness Report that placed the United States 23rd among countries.